The company agreed to potentially sell Synthes’ trauma unit to appease regulators. A ruling is expected by April 26 on the $21.3 billion takeover. Boards of both companies approved the acquisition.
Sign up for our FREE Orthopedic E-Weekly for more coverage like this sent to your inbox!
Related Articles on Orthopedic Devices:
Medtronic’s Biologics Business Down 20% in 3Q With Infuse Sales Dropping
DJO Global Finalizes, Expands Partnership With Lima
ArthroCare Revenues Down in 2011
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.